Saltar al contenido
República del Perú · Observatorio de la producción científica universitaria
OApol.org Observatorio de Inteligencia Científica Universitaria del Perú
OApol.org
Inicio Universidades Publicaciones Investigadores
Repositorios
Tesis y trabajos académicosRevistas
Indicadores
Ranking trimestralRanking por carreraObjetivos de Desarrollo SostenibleReporte OCDERed neuronal 3D
Acerca
MetodologíaPrivacidad

Autoimmune/Inflammatory syndrome induced by adjuvants (ASIA): Neuromyelitis optica spectrum disorder after BBIBP-Cor-V vaccine, case report

Berrú-Villalobos S.; Otiniano-Sifuentes R.; Castro-Suárez S.; Osorio-Marcatinco V.; Guevara-Silva E.; Meza-Vega M.; Caparó-Zamalloa C. · Neuroimmunology Reports (2022) · DOI: 10.1016/j.nerep.2022.100107

Resumen

Background: Recently the term Autoimmune/Inflammatory Syndrome induced by Adjuvants has been proposed to describe different clinical conditions, among them post-vaccinal phenomena like demyelinating diseases. Objective: We aim to add knowledge on the possible association of vaccines and the development of demyelinating diseases. Case report: We present the case of a 38-year-old female that developed a brainstem syndrome after vaccination with COVID-19 BBIBP-CorV Sinopharm Vaccine. The final diagnosis after extensive work-out was Neuromyelitis Optica spectrum disorder with positive Aquaporin 4 positive antibodies; and long-term treatment with Rituximab was initiated. Conclusion: Since we are facing a large-scale vaccination, professionals should be aware of the presence of demyelinating diseases as adverse events for COVID-19 vaccine.

Instituciones: Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos